A recent US Food and Drug Administration (FDA) advisory committee meeting highlighted the potential of clinical pharmacology to overcome challenges in orphan drug development.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/nrd3595 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!